AbbVie breaks ground for a new facility at its Rhineland-Palatinate site in Germany. (Image: AbbVie)
May 3, 2024 02:36 PM EDT
R&D
Pharma

Ab­b­Vie puts $161M in­to new R&D site in Ger­many, will add 300 jobs

Katherine Lewin

News Reporter

Ab­b­Vie is in­vest­ing around €150 mil­lion ($161 mil­lion) in­to an R&D site at its Rhineland-Palati­nate lo­ca­tion in Ger­many which it ex­pects to com­plete in 2027 …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

NewAms­ter­dam aces Phase 3 tri­al, but in­vestors are skep­ti­cal

Post-Hoc: RFK vs. Vivek, and the fu­ture of US drug pol­i­cy

FDA up­dates la­bel of 33-year-old can­cer drug with new dose and warn­ing

When gen­er­a­tive AI meets the FDA: First dig­i­tal health ad­comm kicks off dis­cus­sion

Pfiz­er part­ners with two more Flag­ship biotechs on obe­si­ty, can­cer

sponsored

Are pro­grams with com­pound­ed GLP-1s safe for your pop­u­la­tion?

A service from the Financial Times